A new perfusion model for studying erectile function

Journal of Sexual Medicine

Volumn 7, Issue 4 PART 1, 2010, Pages 1419-1428

  Zhao, Chen ^a   Chae, Han Jung ^a   Kim, Suhn Hee ^a   Cui, Wan Shou ^b   Lee, Sung Won ^c   Jeon, Ju Hong ^d   Park, Jong Kwan ^a  

^a Chonbuk National University   (South Korea)

^b PEKING UNIVERSITY FIRST HOSPITAL   (China)

^c Sungkyunkwan University   (South Korea)

^d Seoul National University College of Medicine   (South Korea)

Author keywords

Basic Science Research in Erectile Dysfunction; Cyclic Nucleotides; In Vitro Penile Perfusion Model; Intracavernosum Pressure (ICP); One Step Procedure; Perfusate; Tension

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; ACETYLCHOLINE; ATROPINE; CYCLIC GMP; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PHENYLEPHRINE; TETRODOTOXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS CAVERNOSUM; ELECTROSTIMULATION; MALE; NONHUMAN; PENIS ERECTION; PERFUSION PRESSURE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TENSION;

EID: 77955248855     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2009.01652.x     Document Type: Article

References (33)

1. Sáenz de Tejada I. In the physiology of erection, signposts to impotence. Contemp Urol 1992, 7:52-68.
2. Andersson KE, Wagner G. Physiology of penile erection. Physiol Rev 1995, 75:191-236.
3. Burnett AL. Nitric oxide in the penis: Physiology and pathology. J Urol 1997, 157:320-4.
4. Stief CG, Noack T, Andersson KE. Signal transduction in cavernous smooth muscle. World J Urol 1997, 15:27-31.
5. Pfaus J. The vermin that help us. J Sex Med 2008, 5:253-6.
6. Jin HR, Kim WJ, Song JS, Choi MJ, Piao S, Shin SH, Tumurbaatar M, Tuvshintur B, Nam MS, Ryu JK, Suh JK. Functional and morphologic characterizations of the diabetic mouse corpus cavernosum: Comparison of a multiple low-dose and a single high-dose streptozotocin protocols. J Sex Med 2009, 6:3289-304.
7. Bivalacqua TJ, Musicki B, Hsu LL, Gladwin MT, Burnett AL, Champion HC. Establishment of a transgenic sickle-cell mouse model to study the pathophysiology of priapism. J Sex Med 2009, 6:2494-504.
8. Claudino MA, Franco-Penteado CF, Corat MA, Gimenes AP, Passos LA, Antunes E, Costa FF. Increased cavernosal relaxations in sickle cell mice priapism are associated with alterations in the NO-cGMP signaling pathway. J Sex Med 2009, 6:2187-96.
9. Carneiro FS, Sturgis LC, Giachini FR, Carneiro ZN, Lima VV, Wynne BM, San Martin S, Brands MW, Tostes RC, Webb RC. TNF-alpha knockout mice have increased corpora cavernosa relaxation. J Sex Med 2009, 6:115-25.
10. Canguven O, Burnett A. Cavernous nerve injury using rodent animal models. J Sex Med 2008, 5:1776-85.
11. Moreland RB, Goldstein II, Kim NN, Traish A. Sildenafil citrate, a selective phosphodiesterase type 5 inhibitor: Research and clinical implications in erectile dysfunction. TEM 1999, 10:97-104.
12. Burnett AL. The role of nitric oxide in erectile dysfunction: Implications for medical therapy. J Clin Hypertens 2006, 8(12):53-62. suppl
13. Ghalayini IF. Nitric oxide-cyclic GMP pathway with some emphasis on cavernosal contractility. Int J Impot Res 2004, 16:459-69.
14. Corbin JD. Mechanisms of action of PDE5 inhibition in erectile dysfunction. Int J Impot Res 2004, 16(1):4-7. suppl
15. Rosen RC, Kostis JB. Overview of phosphodiesterase 5 inhibition in erectile dysfunction. Am J Cardiol 2003, 92:9-18.
16. Gragasin FS, Michelakis ED, Hogan A, Moudgil R, Hashimoto K, Wu X, Bonnet S, Haromy A, Archer SL. The neurovascular mechanism of clitoral erection: Nitric oxide and cGMP-stimulated activation of BKCa channels. FASEB J 2004, 18:1382-91.
17. Filippi S, Vignozzi L, Morelli A, Chavalmane AK, Sarchielli E, Fibbi B, Saad F, Sandner P, Ruggiano P, Vannelli GB, Mannucci E, Maggi M. Testosterone partially ameliorates metabolic profile and erectile responsiveness to PDE5 inhibitors in an animal model of male metabolic syndrome. J Sex Med 2009, 6:3274-88.
18. Chitaley K, Luttrell I. Strain differences in susceptibility to in vivo erectile dysfunction following 6 weeks of induced hyperglycemia in the mouse. J Sex Med 2008, 5:1149-55.
19. Chung SD, Kuo YC, Liu SP, Chang HC, Yu HJ, Hsieh JT. The role of chloride channels in rat corpus cavernosum: In vivo study. J Sex Med 2009, 6:708-16.
20. Morelli A, Chavalmane AK, Filippi S, Fibbi B, Silvestrini E, Sarchielli E, Zhang XH, Vignozzi L, Vannelli GB, Forti G, Maggi M. Atorvastatin ameliorates sildenafil-induced penile erections in experimental diabetes by inhibiting diabetes-induced RhoA/Rho-kinase signaling hyperactivation. J Sex Med 2009, 6:91-106.
21. Sergeant GP, Craven M, Hollywood MA, McHale NG, Thornbury KD. Spontaneous Ca2+ waves in rabbit corpus cavernosum: Modulation by nitric oxide and cGMP. J Sex Med 2009, 6:958-66.
22. Park JK, Cui Y, Kim MK, Kim YG, Kim SH, Kim SZ, Cho KW. Effects of extracorporeal shock wave lithotripsy on plasma levels of nitric oxide and cyclic nucleotides in human subjects. J Urol 2002, 168:38-42.
23. Park JK, Kim SZ, Kim SH, Park YK, Cho KW. Renin angiotensin system in rabbit corpus cavernosum: Functional characterization of angiotensin II receptors. J Urol 1997, 158:653-8.
24. Moncada S, Higgs EA. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 1995, 9:1319-30.
25. Park JK, Kim JU, Lee SO, Hwang PH, Yi HK, Kim YG, Cho KW. Nitric oxide-cyclic GMP signaling pathway in the regulation of rabbit clitoral cavernosum tone. Exp Biol Med 2002, 227:1022-30.
26. Gur S, Kadowitz PJ, Trost L, Hellstrom WJ. Optimizing nitric oxide production by time dependent L-arginine administration in isolated human corpus cavernosum. J Urol 2007, 178:1543-8.
27. Angulo J, Cuevas P, Fernández A, Gabancho S, Allona A, Martín-Morales A, Moncada I, Videla S, Sáenz de Tejada I. Diabetes impairs endothelium-dependent relaxation of human penile vascular tissues mediated by NO and EDHF. Biochem Biophys Res Commun 2003, 312:1202-8.
28. Hallén K, Wiklund NP, Gustafsson LE. Inhibitors of phosphodiesterase 5 (PDE 5) inhibit the nerve-induced release of nitric oxide from the rabbit corpus cavernosum. Br J Pharmacol 2007, 150:353-60.
29. Kuwahara T, Wada Y, Takahashi W, Yoshida M, Iwashita H, Kikukawa H, Nakanishi J, Ueda S. Effects of diabetes on nitric oxide-mediated relaxations in male rat corpus cavernosum smooth muscle. Urol Int 2003, 71:399-407.
30. Goçmen C, Ucar P, Singirik E, Dikmen A, Baysal F. An in vitro study of nonadrenergic-noncholinergic activity on the cavernous tissue of mouse. Urol Res 1997, 25:269-75.
31. Ignarro LJ, Bush PA, Buga GM, Wood KS, Fukuto JM, Rajfer J. Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle. Biochem Biophys Res Commun 1990, 170:843-50.
32. Aydinoglu F, Yilmaz SN, Coskun B, Daglioglu N, Ogulener N. Effects of ethanol treatment on the neurogenic and endothelium-dependent relaxation of corpus cavernosum smooth muscle in the mouse. Pharmacol Rep 2008, 60:725-34.
33. Carneiro FS, Giachini FR, Lima VV, Carneiro ZN, Leite R, Inscho EW, Tostes RC, Webb RC. Adenosine actions are preserved in corpus cavernosum from obese and type II diabetic db/db mouse. J Sex Med 2008, 5:1156-66.